Clinical Trials Sponsored by Melanoma Research Institute

Total 16933 results

Northern California Melanoma Center
Bayer; Melanoma Research Institute

Completed

GM-CSF as Adjuvant Therapy of Melanoma

Malignant Melanoma

United States
Melanoma Institute Australia

Recruiting

A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma (SONIB)

Skin Cancer | Basal Cell Carcinoma | Invasive Carcinoma | Basal Cell Carcinoma of Skin, Site Unspecified

Australia
Melanoma Institute Australia

Active, not recruiting

Neoadjuvant Dabrafenib + Trametinib for AJCC Stage IIIB-C BRAF V600 Mutation Positive Melanoma (Neo Combi)

Melanoma

Australia
Melanoma Institute Australia

Withdrawn

Intralesional Sclerosant for in Transit and Cutaneous Melanoma Metastases (INTRANS)

Melanoma | In-Transit Metastasis of Cutaneous Melanoma

Australia
Saint John's Cancer Institute
Melanoma Research Alliance

Terminated

Stage IV Surgery Versus Best Medical Therapy (STG4SURG)

Stage IV Resectable Melanoma

United States, Australia, Israel, Italy, Netherlands
Melanoma Institute Australia
Novartis

Recruiting

Molecular Profiling and Matched Targeted Therapy for Patients With Metastatic Melanoma (MatchMel)

Melanoma

Australia
Melanoma and Skin Cancer Trials Limited
Melanoma Institute Australia

Active, not recruiting

Radiotherapy or Imiquimod in Complex Lentigo Maligna (RADICAL)

Lentigo Maligna

Australia, Brazil, New Zealand
Melanoma and Skin Cancer Trials Limited
Melanoma Institute Australia

Completed

Radiotherapy & Combi in Metastatic Melanoma (CombiRT)

Metastatic Melanoma

Australia
University of Minnesota
Melanoma Research Alliance

Withdrawn

Pilot Study of Intervention to Reduce Sunburns in Melanoma Survivors

Melanoma (Skin)
Melanoma Institute Australia
Bristol-Myers Squibb

Recruiting

Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma

Merkel Cell Carcinoma

Australia
Melanoma Institute Australia
Bristol-Myers Squibb

Recruiting

Anti-PD 1 Brain Collaboration + Radiotherapy Extension (ABC-X Study) (ABC-X)

Melanoma Stage Iv

Australia, Norway
Fondazione Melanoma Onlus
Clinical Research Technology S.r.l.

Active, not recruiting

Sequential Combo Immuno and Target Therapy (SECOMBIT) Study (SECOMBIT)

Metastatic Melanoma

Italy, Germany, Spain, Greece, Austria, France, Poland, Sweden, Switzerland, United Kingdom
Melanoma Research Foundation Breakthrough Consortium
Genentech, Inc.

Terminated

Trial of Vemurafenib/Cobimetinib With or Without Bevacizumab in Patients With Stage IV BRAFV600 Mutant Melanoma

Melanoma | Metastatic Melanoma

United States
Melanoma Institute Australia
Bristol-Myers Squibb; Melanoma and Skin Cancer Trials Limited

Active, not recruiting

Anti-PD 1 Brain Collaboration for Patients With Melanoma Brain Metastases (ABC)

Melanoma | Brain Metastases

Australia
Melanoma Institute Australia
Bristol-Myers Squibb

Not yet recruiting

Neoadjuvant Nivolumab and Relatlimab in Cutaneous Squamous Cell Carcinoma

Cutaneous Squamous Cell Carcinoma
Melanoma Institute Australia
Bristol-Myers Squibb

Recruiting

A Phase 2 Clinical Trial of Neoadjuvant Relatlimab and Nivolumab in High Risk, Clinical Stage II Cutaneous Melanoma (Neo ReNi II)

Stage II Melanoma

Australia
Fondazione Melanoma Onlus
Clinical Research Technology S.r.l.

Active, not recruiting

Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma (NEO-TIM)

Melanoma

Italy
Georgetown University
Genentech, Inc.; Melanoma Research Alliance

Terminated

The Effects of Vemurafenib + Cobimetinib on Immunity in Patients With Melanoma

Melanoma

United States
Melanoma and Skin Cancer Trials Limited
Melanoma Institute Australia; Cancer Council New South Wales

Active, not recruiting

Evaluation of Groin Lymphadenectomy Extent For Metastatic Melanoma (EAGLE FM)

Metastatic Melanoma to the Groin Lymph Nodes

United Kingdom, Slovenia, Australia, Brazil, Netherlands, Italy
Piramal Enterprises Limited
Melanoma Research Foundation Breakthrough Consortium

Suspended

Study of an Oral Cdk Inhibitor Administered With an Oral BRAF Inhibitor in Patients With Advanced or Inoperable Malignant Melanoma With BRAF Mutation

Advanced or Inoperable Malignant Melanoma With BRAF Mutation

United States
Melanoma Institute Australia
Merck Sharp & Dohme LLC

Not yet recruiting

Neoadjuvant Pembrolizumab and Lenvatinib for Mucosal Melanoma (Neo PeLeMM)

Mucosal Melanoma

Australia
Melanoma Institute Australia
Merck Sharp & Dohme LLC

Active, not recruiting

A Phase II Study of Neoadjuvant Pembrolizumab & Lenvatinib for Resectable Stage III Melanoma (Neo PeLe)

Melanoma Stage III

Australia
Shaheer A. Khan
AstraZeneca; Melanoma Research Alliance

Completed

Intermittent Selumetinib for Uveal Melanoma

Uveal Melanoma

United States
OHSU Knight Cancer Institute
Oregon Health and Science University; Melanoma Research Foundation

Recruiting

War on Melanoma™ Public Health & Education Campaign

Melanoma

United States
Melanoma Institute Australia
Merck Sharp & Dohme LLC; Novartis

Active, not recruiting

Neoadjuvant Dabrafenib, Trametinib and/or Pembrolizumab in BRAF Mutant Resectable Stage III Melanoma (Neo Trio)

Melanoma

Australia
University of Minnesota
American Cancer Society, Inc.; Melanoma Research Alliance

Completed

Wearable Device Intervention to Improve Sun Behaviors in Melanoma Survivors

Melanoma (Skin)

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...
Melanoma Research Alliance

Completed

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

Melanoma | Non-small Cell Lung Cancer (NSCLC) | Renal Cell Carcinoma (RCC)

United States
Northwestern University
Bristol-Myers Squibb; American Cancer Society, Inc.; Melanoma Research Foundation...

Completed

Development of ImmunOncoTool (ACS-MRA)

Cancer | Cancer, Treatment-Related

United States
Hassane M. Zarour, MD
Merck Sharp & Dohme LLC; Melanoma Research Alliance

Completed

Treatment of Advanced Melanoma With MK-3475 and Peginterferon

Melanoma

United States
Nina Bhardwaj
Memorial Sloan Kettering Cancer Center; NYU Langone Health; Ludwig Institute... and other collaborators

Completed

A Comparison of Matured Dendritic Cells and Montanide® in Study Subjects With High Risk of Melanoma Recurrence

Melanoma

United States
Karolinska Institutet
Patient-Centered Outcomes Research Institute; Kaiser Foundation Research Institute

Active, not recruiting

COMparison Between All immunoTherapies for Multiple Sclerosis. (COMBAT-MS)

Relapsing-remitting Multiple Sclerosis

Sweden
Karolinska Institutet
Children's National Research Institute

Completed

Resistance Exercise Reduces the Expression of Inflammation and Fibrosis Associated Genes in Autoimmune Myositis Patients

Exercise | Myositis

Sweden
Bruyere Research Institute
Canadian Institutes of Health Research (CIHR)

Unknown

The PIP-STOPP Study (PIP-STOPP)

Potentially Inappropriate Prescribing (PIP)
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR)

Recruiting

The STRIVE Before Surgery Pilot Trial

Disability Physical | Surgery-Complications

Canada
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR)

Not yet recruiting

The UCAP 2 Pilot Study

Asthma | COPD

Canada
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR)

Recruiting

Reducing Low-Value Preoperative Investigations in Patients Undergoing Low Risk Surgery (Pre-Op)

Surgery | Anesthesiology

Canada
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR)

Recruiting

Cam Type FAI is a Cause of Hip Pain in the Young Adult and a Precursor to OA

Osteoarthritis | Hip Dysplasia | Femoroacetabular Impingement

Canada
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR)

Recruiting

Exercise in Patients With End Stage Kidney Disease

Renal Failure

Canada
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR)

Recruiting

SAHaRA: A Randomized Controlled Trial

Subarachnoid Hemorrhage, Aneurysmal

United States, Australia, Canada
Population Health Research Institute
Canadian Institutes of Health Research (CIHR)

Completed

Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot Study (COP-AF Pilot)

Atrial Fibrillation | Thoracic Surgery

Canada
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR)

Completed

Cellular Immunotherapy for Septic Shock: A Phase I Trial (CISS)

Septic Shock

Canada
Lawson Health Research Institute
Canadian Institutes of Health Research (CIHR)

Completed

Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia (IEMO)

Frontotemporal Dementia

Canada
Lawson Health Research Institute
Canadian Institutes of Health Research (CIHR)

Completed

Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate Cancer (IGPC-3)

Prostate Cancer

Canada
Lawson Health Research Institute
Canadian Institutes of Health Research (CIHR)

Unknown

Detecting Radiation-Induced Cardiac Toxicity After Non-Small Cell Lung Cancer Radiotherapy (RICT-LUNG)

Non-small Cell Lung Cancer | Radiation Toxicity

Canada
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR)

Completed

PROSPER: PostpaRtum PrOphylaxiS for PE Randomized Control Trial Pilot (PROSPER)

Venous Thromboembolism | Postpartum

Canada, United States
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR)

Completed

Weaning And Variability Evaluation (WAVE)

Mechanically Ventilated Patients | Extubation

United States, Canada
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR)

Withdrawn

Creating a Tissue Bank of Knee Capsules

Osteoarthritis | Knee Joint Contractures

Canada
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR)

Completed

Implementation of the Canadian C-Spine Rule

Cspine Injury

Canada
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR)

Completed

TIPPS: Thrombophilia in Pregnancy Prophylaxis Study (TIPPS)

Pregnancy Complications | Pregnancy | Thrombophilia

Canada, United States
Lawson Health Research Institute
Canadian Institutes of Health Research (CIHR)

Completed

Activity and Metformin Intervention in Obese Adolescents (REACH)

Obesity | Type 2 Diabetes

Canada

Clinical Trials Sponsored by Melanoma Research Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations